Fetal RhD NIPT: A new testing option to inform care for RhD alloimmunized patients and those at risk
Natera™'s Fetal RhD NIPT (noninvasive prenatal testing) is now available. The test is backed by the largest clinical validation study for fetal RhD in the US to date, and demonstrated 100 percent sensitivity, 99.3 percent specificity.